20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Ocular Therapeutix, Inc. (NASDAQ:OCUL) shares are trading lower in Wednesday's after-hours session. The company announced that it commenced an underwritten public offering of its common stock.
What To Know: While the size, terms and time frame of the offering were not provided, the company is anticipated to grant a 30-day option to purchase up to an additional 15% of the number of shares of common stock from the offering to the underwriters.
Additionally, all of the shares in the proposed offering are to be sold by the company.
The net proceeds from the proposed offering are planned to be used to fund the Phase 3 clinical development of AXPAXLI, as well as to support the company's clinical development programs and for working capital and other general corporate purposes.
Related Link: Why Amtech Stock Plunged After-Hours
OCUL Price Action: Shares of OCUL were down 15.48% at $3.33 in the after-hours session Wednesday at the time of publication, according to Benzinga Pro.
Photo: Triggermouse from Pixabay
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!